Related references
Note: Only part of the references are listed.CDK inhibitors: Cell cycle regulators and beyond
Arnaud Besson et al.
DEVELOPMENTAL CELL (2008)
Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function
Natalie C. Jones et al.
NATURE MEDICINE (2008)
Apoptosis by cisplatin requires p53 mediated p38α MAPK activation through ROS generation
Paloma Bragado et al.
APOPTOSIS (2007)
Efficient nucleofection of primary human B cells and B-CLL cells induces apoptosis, which depends on the microenvironment and on the structure of transfected nucleic acids
M. Seiffert et al.
LEUKEMIA (2007)
Delayed neuronal death after brain trauma involves p53-dependent inhibition of NF-κB transcriptional activity
N. Plesnila et al.
CELL DEATH AND DIFFERENTIATION (2007)
The Bcl-2 apoptotic switch in cancer development and therapy
J. M. Adams et al.
ONCOGENE (2007)
Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak
Simon N. Willis et al.
SCIENCE (2007)
Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737
Victoria Del Gaizo Moore et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
TEL/ETV6 induces apoptosis in 32D cells through p53-dependent pathways
Tetsuya Yamagata et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia
Kensuke Kojima et al.
BLOOD (2006)
Regulation of PUMA-α by p53 in cisplatin-induced renal cell apoptosis
M. Jiang et al.
ONCOGENE (2006)
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL)
Paola Secchiero et al.
BLOOD (2006)
MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells
Llorenc Coll-Mulet et al.
BLOOD (2006)
Trp53 loss during in vitro selection contributes to acquired Ara-C resistance in acute myeloid leukemia
Bin Yin et al.
EXPERIMENTAL HEMATOLOGY (2006)
Modulation of p53 transcriptional activity by PRIMA-1 and Pifithrin-α on staurosporine-induced apoptosis of wild-type and mutated p53 epithelial cells
J. F. Charlot et al.
APOPTOSIS (2006)
WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization
Y Tomita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Topotecan-triggered degradation of topoisomerase I is p53-dependent and impacts cell survival
MT Tomicic et al.
CANCER RESEARCH (2005)
p53 isoforms can regulate p53 transcriptional activity
JC Bourdon et al.
GENES & DEVELOPMENT (2005)
p53-dependent caspase-2 activation in mitochondrial release of apoptosis-inducing factor and its role in renal tubular epithelial cell injury
R Seth et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Inhibitors of XIAP sensitize CD40-activated chronic lymphocytic leukemia cells to CD95-mediated apoptosis
AP Kater et al.
BLOOD (2005)
Prospective therapeutic applications of p53 inhibitors
AV Gudkov et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Puma and p53 play required roles in death evoked in a cellular model of Parkinson disease
SC Biswas et al.
NEUROCHEMICAL RESEARCH (2005)
Mechanisms of disease: Chronic lymphocytic leukemia
N Chiorazzi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis
JE Chipuk et al.
SCIENCE (2004)
Defining the p53 DNA-binding domain BcL-XL-binding interface using NMR
AM Petros et al.
FEBS LETTERS (2004)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
Wild-type p53 activates SAP expression in lymphoid cells
N Nagy et al.
ONCOGENE (2004)
Microarray analysis reveals that TP53-and ATM-mutant B-CLLs share a defect in activating proapoptotic responses after DNA damage but are distinguished by major differences in activating prosurvival responses
T Stankovic et al.
BLOOD (2004)
Bax conformational change is a crucial step for PUMA-mediated apoptosis in human leukemia
FT Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Microarray analysis of p53 target gene expression patterns in the spleen and thymus in response to ionizing radiation
TF Burns et al.
CANCER BIOLOGY & THERAPY (2003)
Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis
DT Jones et al.
BLOOD (2003)
Inhibition of p53 protects liver tissue against endotoxin-induced apoptotic and necrotic cell death
T Schäfer et al.
FASEB JOURNAL (2003)
p53 has a direct apoptogenic role at the mitochondria
M Mihara et al.
MOLECULAR CELL (2003)
The p53-Mdm2 module and the ubiquitin system
D Michael et al.
SEMINARS IN CANCER BIOLOGY (2003)
Live or let die: The cell's response to p53
KH Vousden et al.
NATURE REVIEWS CANCER (2002)
A phase I study of fludarabine combined with radiotherapy in patients with intermediate to locally advanced head and neck squamous cell carcinoma
V Grégoire et al.
RADIOTHERAPY AND ONCOLOGY (2002)
Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or γ radiation
DT Jones et al.
BLOOD (2001)
p53 dysfunction in B-cell chronic lymphocytic leukemia:: inactivation of ATM as an alternative to TP53 mutation
AR Pettitt et al.
BLOOD (2001)
Pharmacokinetics of chlorambucil in patients with chronic lymphocytic leukaemia:: Comparison of different days, cycles and doses
R Silvennoinen et al.
PHARMACOLOGY & TOXICOLOGY (2000)
Share Paper
